Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 130

    1.

    Clinical trials and basic research: defining mechanisms and improving treatment in connective tissue disease.

    Rubin LJ, Black CM, Denton CP, Seibold JR.

    Arthritis Res Ther. 2007;9 Suppl 2:S10. Review.

    PMID:
    17767739
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    2.

    Therapeutic trials for systemic sclerosis: an update.

    Sardana K, Garg VK.

    Indian J Dermatol Venereol Leprol. 2008 Sep-Oct;74(5):436-46. Review.

    PMID:
    19052400
    [PubMed - indexed for MEDLINE]
    Free Article
    3.

    Clinical trials in systemic sclerosis: lessons learned and outcomes.

    Matucci-Cerinic M, Steen VD, Furst DE, Seibold JR.

    Arthritis Res Ther. 2007;9 Suppl 2:S7. Review.

    PMID:
    17767745
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    4.

    Clinical trials: types, design, and end-points.

    Seibold JR.

    Curr Opin Rheumatol. 2001 Nov;13(6):512-5. Review.

    PMID:
    11698730
    [PubMed - indexed for MEDLINE]
    5.

    Clinical trial design in systemic lupus erythematosus.

    Dall'Era M, Wofsy D.

    Curr Opin Rheumatol. 2006 Sep;18(5):476-80. Review.

    PMID:
    16896285
    [PubMed - indexed for MEDLINE]
    6.

    Cellular therapy of systemic sclerosis.

    van Laar JM, Tyndall A.

    Curr Rheumatol Rep. 2008 Jul;10(3):189-94. Review.

    PMID:
    18638426
    [PubMed - indexed for MEDLINE]
    7.

    Therapeutic targets in systemic sclerosis.

    Denton CP.

    Arthritis Res Ther. 2007;9 Suppl 2:S6. Review.

    PMID:
    17767744
    [PubMed - indexed for MEDLINE]
    Free PMC Article
    8.

    The EULAR Scleroderma Trials and Research Group (EUSTAR): an international framework for accelerating scleroderma research.

    Tyndall A, Ladner UM, Matucci-Cerinic M.

    Curr Opin Rheumatol. 2008 Nov;20(6):703-6. Review.

    PMID:
    18946332
    [PubMed - indexed for MEDLINE]
    9.

    Current clinical trials in amyotrophic lateral sclerosis.

    Bhatt JM, Gordon PH.

    Expert Opin Investig Drugs. 2007 Aug;16(8):1197-207. Review.

    PMID:
    17685869
    [PubMed - indexed for MEDLINE]
    10.

    Recent advances on pathogenesis and therapies in systemic sclerosis.

    Yazawa N, Fujimoto M, Tamaki K.

    Clin Rev Allergy Immunol. 2007 Oct;33(1-2):107-12. Review.

    PMID:
    18064573
    [PubMed - indexed for MEDLINE]
    11.

    Treatment of scleroderma.

    Gelber AC, Wigley FM.

    Curr Opin Rheumatol. 1995 Nov;7(6):551-9. Review.

    PMID:
    8579978
    [PubMed - indexed for MEDLINE]
    12.

    Recent advances in the treatment of systemic sclerosis.

    Bournia VK, Vlachoyiannopoulos PG, Selmi C, Moutsopoulos HM, Gershwin ME.

    Clin Rev Allergy Immunol. 2009 Jun;36(2-3):176-200. Review.

    PMID:
    19132559
    [PubMed - indexed for MEDLINE]
    13.

    Overview of resistance to systemic therapy in patients with breast cancer.

    Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

    Adv Exp Med Biol. 2007;608:1-22. Review.

    PMID:
    17993229
    [PubMed - indexed for MEDLINE]
    14.

    The application of disease management to clinical trial designs.

    Puterman J, Alter DA.

    Popul Health Manag. 2009 Aug;12(4):205-8.

    PMID:
    19663623
    [PubMed - indexed for MEDLINE]
    15.

    Pathogenesis and therapeutic approaches for improved topical treatment in localized scleroderma and systemic sclerosis.

    Badea I, Taylor M, Rosenberg A, Foldvari M.

    Rheumatology (Oxford). 2009 Mar;48(3):213-21. Epub 2008 Nov 20. Review.

    PMID:
    19022832
    [PubMed - indexed for MEDLINE]
    Free Article
    16.

    Design and endpoints of clinical trials in hepatocellular carcinoma.

    Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, Schwartz M, Lotze M, Talwalkar J, Gores GJ; Panel of Experts in HCC-Design Clinical Trials.

    J Natl Cancer Inst. 2008 May 21;100(10):698-711. Epub 2008 May 13. Review.

    PMID:
    18477802
    [PubMed - indexed for MEDLINE]
    Free Article
    17.

    Current topics in the diagnosis and treatment of scleroderma.

    Barr WG.

    Compr Ther. 1991 Jun;17(6):39-45. Review.

    PMID:
    1934987
    [PubMed - indexed for MEDLINE]
    18.

    European League Against Rheumatism (EULAR) Scleroderma Trial and Research group (EUSTAR) recommendations for the treatment of systemic sclerosis: methods of elaboration and results of systematic literature research.

    Avouac J, Kowal-Bielecka O, Landewe R, Chwiesko S, Miniati I, Czirjak L, Clements P, Denton C, Farge D, Fligelstone K, Földvari I, Furst DE, Müller-Ladner U, Seibold J, Silver RM, Takehara K, Toth BG, Tyndall A, Valentini G, van den Hoogen F, Wigley F, Zulian F, Matucci-Cerinic M; EUSTAR Coauthors.

    Ann Rheum Dis. 2009 May;68(5):629-34. Epub 2008 Oct 28.

    PMID:
    18957486
    [PubMed - indexed for MEDLINE]
    19.

    Scleroderma: pathogenic factors and current management.

    Penny R.

    Aust N Z J Med. 1978;8 Suppl 1:143-8. Review.

    PMID:
    365159
    [PubMed - indexed for MEDLINE]
    20.

    Targeted therapy comes of age in scleroderma.

    Denton CP, Black CM.

    Trends Immunol. 2005 Nov;26(11):596-602. Epub 2005 Sep 15. Review.

    PMID:
    16168710
    [PubMed - indexed for MEDLINE]

      Display Settings:

      Format
      Items per page
      Sort by

      Send to:

      Choose Destination

      Supplemental Content

      Find related data

      Write to the Help Desk